Hot water extracts of Mo-er (1 gm by 15 ml of water), an oriental food (Auricularia auricula), inhibit strongly both human and rat platelet ADP-induced aggregation. HPLC analysis of two varieties of Mo-er, A.auricula and A.polytricha (a black tree fungus), shows that they contain adenosine (Ado), 133 and 154 micrograms per gram of dry fungus, respectively. The inhibition of ADP-induced platelet aggregation by Mo-er extracts and by Ado was compared. Mo-er extracts caused a more rapid onset and a longer duration of inhibition than produced by equivalent amounts of Ado. Furthermore, Mo-er extract treated with adenosine deaminase to degrade the Ado retained the capacity to inhibit platelet aggregation. The inhibitory effects of Mo-er extracts on ADP-induced human platelet aggregation are greatly potentiated by the inhibitors of cyclic AMP phosphodiesterase such as oxagrelate (phthalazinol) and papaverine. The inhibition of platelet aggregation is only partially blocked by 2’,5’-dideoxy-adenosine (DDA), an inhibitor of platelet adenylate cyclase and 5’-deoxy, 5’-methylthioadenosine (MTA), an antagonist of Ado receptors. ADP-induced rat platelet aggregation is strongly inhibited by Mo-er extracts, but not by Ado. This inhibition is not reversed by either DDA or MTA. These findings indicate that Mo-er extracts contain an agent (or agents) in addition to Ado, that blocks platelet aggregation by a mechanism that does not involve the platelet cyclic AMP system.
Keywords
Human -
Rat -
Platelets
* Supported by USPHS Grants CA 07340 and CA 13943
References
1
Hammerschmidt DE.
Szechwan Purpura. N Engl J Med 1980; 302: 1191-1193
4
Agarwal RP,
Sagar SM,
Parks Jr RE.
Adenosine deaminase from human erythrocytes: purification and effects of adenosine analogs. Biochem Pharmacol 1975; 24: 693-701
5
Agarwal KC,
Parks Jr RE.
Adenosine analogs and human platelets: effects on nucleotide pools and the aggregation phenomenon. Biochem Pharmacol 1975; 24: 2239-2248
6
Agarwal KC,
Parks Jr RE,
Townsend LB.
Adenosine analogs and human platelets II: inhibition of ADP-induced aggregation by car-bocyclic adenosine and imidazole-ring modified analogs. Significance of alterations in the nucleotide pools. Biochem Pharmacol 1979; 28: 501-510
7
Agarwal KC,
Parks Jr RE.
5'-methylthioadenosine and 2',5'-dideoxyadenosine blockade of the inhibitory effects of adenosine on ADP-induced platelet aggregation by different mechanisms. Biochem Pharmacol 1980; 29: 2529-2532
8
Hidaka H,
Asano T,
Ochiai Y.
Selective inhibition of separated forms of human platelet cyclic nucleotide phosphodiesterase by platelet aggregation inhibitors. Molec Pharmacol 1977; 13: 400-406
9
Agarwal KC,
Haskel EJ,
Parks Jr RE.
Effects of adenosine analogs and adenine nucleotides on adenosine 5'-diphosphate-induced rat platelet aggregation. Biochem Pharmacol 1980; 29: 1799-1805
10
Haskel EJ,
Agarwal KC,
Parks Jr RE.
ATP- and ADP-induced rat platelet aggregation: significance of plasma in ATP-induced aggregation. Thromb Haemostas 1980; 42: 1580-1588
12
Marquis NR,
Vigdahl RL,
Tavormina PA.
Platelet aggregation I. Regulation by cyclic AMP and prostaglandin E1
. Biochem Biophys Res Comm 1969; 36: 965-972
13
Mills DCB,
Smith JB.
The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3', 5'-cyclic monophosphate in platelets. Biochem J 1971; 121: 185-196
14
Moneada S,
Korbut R.
Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin. Lancet 1978; I: 1286-1289
